Fast and efficient clinical trials are more important now than ever before. Advancement in technology is allowing the opportunity to perform trials on digital patients rather than a living person. This technology has the potential to decrease the development time and costs associated with clinical trials, and can help identify vaccines that are less likely to work sooner, thereby allowing researchers to perform trials more often.

While this medical technology is not new, many hurdles exist before widespread implementation. It can take a considerable amount of time and money to develop a simulation of high-quality and diverse patient databases. The U.S. Food and Drug Administration is already using computer simulations in place of human trials for evaluating new disease identification technologies. Computer-based diagnostics can deliver cost-effective value for patients, clinicians, and healthcare organizations.

Read more about this technology at Scientific American.